Results     25-May-16
Announcements
Astrazeneca Pharma India standalone net profit declines 98.53% in the March 2016 quarter
Sales rise 10.52% to Rs 133.51 crore
Net profit of Astrazeneca Pharma India declined 98.53% to Rs 0.56 crore in the quarter ended March 2016 as against Rs 38.13 crore during the previous quarter ended March 2015. Sales rose 10.52% to Rs 133.51 crore in the quarter ended March 2016 as against Rs 120.80 crore during the previous quarter ended March 2015.

For the full year,net profit reported to Rs 5.26 crore in the year ended March 2016 as against net loss of Rs 20.84 crore during the previous year ended March 2015. Sales rose 12.24% to Rs 526.46 crore in the year ended March 2016 as against Rs 469.05 crore during the previous year ended March 2015.

ParticularsQuarter EndedYear Ended
 Mar. 2016Mar. 2015% Var.Mar. 2016Mar. 2015% Var.
Sales133.51120.80 11 526.46469.05 12
OPM %2.4033.77 -3.12-2.43 -
PBDT5.3042.15 -87 23.19-5.56 LP
PBT1.0638.13 -97 5.76-20.84 LP
NP0.5638.13 -99 5.26-20.84 LP

Previous News
  Astrazeneca Pharma India announces board meeting date
 ( Corporate News - 02-Feb-22   11:28 )
  Astrazeneca Pharma India schedules board meeting
 ( Corporate News - 25-May-23   15:01 )
  Board of Astrazeneca Pharma India recommends Final Dividend
 ( Corporate News - 28-May-22   10:09 )
  Board of Astrazeneca Pharma India recommends final dividend
 ( Corporate News - 28-May-24   09:52 )
  AstraZeneca Pharma hits 52 week high after Q1 PAT soars to Rs 54 cr
 ( Hot Pursuit - 14-Aug-23   16:04 )
  AstraZeneca receives DCGI approval for launch of Olaparib Film-Coated tablets in India
 ( Corporate News - 19-Aug-22   19:06 )
  Astrazeneca Pharma India schedules AGM
 ( Corporate News - 25-Jul-23   09:45 )
  Astrazeneca Pharma India schedules board meeting
 ( Corporate News - 04-Aug-20   10:39 )
  Astrazeneca Pharma India to hold board meeting
 ( Corporate News - 22-Jan-20   10:30 )
  AstraZeneca receives import and market permission for Acalabrutinib 100mg capsules
 ( Corporate News - 13-Mar-20   10:07 )
  Astrazeneca Pharma India standalone net profit rises 3322.50% in the September 2017 quarter
 ( Results - Announcements 07-Nov-17   16:18 )
Other Stories
  Shri Bholanath Carpets reports standalone net profit of Rs 0.02 crore in the June 2024 quarter
  30-Sep-24   07:34
  Gala Precision Engineering consolidated net profit rises 38.55% in the June 2024 quarter
  30-Sep-24   07:34
  Kross standalone net profit declines 4.25% in the June 2024 quarter
  28-Sep-24   07:36
  Jamna Auto Industries consolidated net profit rises 1.73% in the June 2024 quarter
  28-Sep-24   07:35
  Baazar Style Retail reports standalone net loss of Rs 0.39 crore in the June 2024 quarter
  26-Sep-24   07:35
  Mysore Paper Mills reports standalone net loss of Rs 22.19 crore in the June 2024 quarter
  26-Sep-24   07:35
  Educomp Solutions reports standalone net loss of Rs 1.81 crore in the June 2024 quarter
  25-Sep-24   07:30
  Ecos (India) Mobility & Hospitality consolidated net profit declines 3.08% in the June 2024 quarter
  25-Sep-24   07:30
  Orissa Minerals Development Company reports standalone net loss of Rs 2.08 crore in the June 2024 quarter
  24-Sep-24   07:43
  Apis India consolidated net profit declines 40.92% in the June 2024 quarter
  21-Sep-24   07:30
Back Top